{"id":"NCT01610037","sponsor":"Novartis Pharmaceuticals","briefTitle":"Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation","officialTitle":"A Placebo and Active Controlled Study to Assess the Long-term Safety of Once Daily QVA149 for 52 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients With Moderate to Severe Airflow Limitation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10","primaryCompletion":"2015-02","completion":"2015-02","firstPosted":"2012-06-01","resultsPosted":"2016-06-15","lastUpdate":"2016-06-15"},"enrollment":1215,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"QVA149","otherNames":[]},{"type":"DRUG","name":"Tiotropium","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"QVA149","type":"EXPERIMENTAL"},{"label":"Tiotropium","type":"ACTIVE_COMPARATOR"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The study will assess the long-term safety of the fixed combination product QVA149 versus placebo and a standard of care treatment (tiotropium) in Chronic Obstructive Pulmonary Disease (COPD) patients with moderate to severe airflow limitation.","primaryOutcome":{"measure":"Number of Patients With Serious Adverse Events","timeFrame":"Week 52","effectByArm":[{"arm":"QVA149","deltaMin":55,"sd":null},{"arm":"Tiotropium 18 µg o.d","deltaMin":55,"sd":null},{"arm":"Placebo","deltaMin":50,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":116,"countries":["Argentina","Colombia","Croatia","Estonia","Hungary","India","Israel","Latvia","Mexico","Panama","Poland","Russia","Serbia","Slovenia","South Korea","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":55,"n":407},"commonTop":["Chronic obstructive pulmonary disease","Nasopharyngitis","Upper respiratory tract infection bacterial","Upper respiratory tract infection","Cough"]}}